Table of Contents
Patents, Trademarks, Licenses, Franchises, Concessions, Royalty Agreements or Labor Contracts, Including Duration
We currently protect our intellectual property through patents, trademarks, designs and copyrights on our products and services. We
have used and, to a limited extent, continue to use intellectual property harnessed from our analytical reference standards and services
segment to create new proprietary ingredients to our customers. We aim to develop these proprietary ingredients ourselves and grant
licenses to external companies for their commercialization.
The following table sets forth our existing patents and those to which we have licensed rights:
Patent
Number Title Filling Date Issued Date Expires Licensor
7,776,326 Methods and compositions for treating
neuropathies
6/3/2005 8/17/2010 6/24/2026 Licensed from Washington University
8,106,184 Nicotinyl Riboside Compositions and
Methods of Use
11/17/2006 1/31/2012 9/20/2027 Licensed from Cornell University
8,114,626 Yeast strain and method for using the same to
produce Nicotinamide Riboside
3/26/2009 2/14/2012 1/5/2026 Licensed from Dartmouth College
8,889,126 Methods and compositions for treating
neuropathies
5/28/2010 11/18/2014 6/3/2025 Licensed from Washington University
9,000,147 Nicotyl riboside compositions and methods of
use
1/17/2012 4/7/2015 11/17/2026 Licensed from Cornell University
9,295,688 Methods and compositions for treating
neuropathies
10/10/2014 3/29/2016 6/3/2025 Licensed from Washington University
9,321,797 Nicotyl riboside compositions and methods of
use
11/17/2014 4/26/2016 11/17/2026 Licensed from Cornell University
9,975,915 Crystalline forms of nicotinoyl ribosides,
modified derivatives thereof, and
phosphorylated analogs thereof, and methods
of preparation thereof
11/10/2017 5/22/2018 11/10/2037 Co-owned with The Queen’s
University of Belfast and exclusively
licensed by ChromaDex
10,000,519 Methods of Preparing Nicotinamide Riboside
and Derivatives Thereof
7/24/2014 6/19/2018 7/24/2034 Licensed from The Queen’s University
of Belfast
10,000,520 B-vitamin and amino acid conjugates of
nicotinoyl ribosides and reduced nicotinoyl
ribosides, derivatives thereof, and methods of
preparation thereof
3/16/2017 6/19/2018 3/16/2037 Co-owned with The Queen’s
University of Belfast and exclusively
licensed by ChromaDex
10,183,036 Use of nicotinic acid riboside or nicotinamide
riboside derivatives, and reduced derivatives
thereof, as NAD+ increasing precursors
4/20/2017 1/22/2019 4/20/2037 Owned by ChromaDex
10,280,190 Nicotinic acid riboside or nicotinamide
riboside compositions, reduced derivatives
thereof, and the use thereof to enhance skin
permeation in treating skin conditions
3/16/2016 5/7/2019 5/31/2036 Co-owned with The Queen’s
University of Belfast and exclusively
licensed by ChromaDex
10,688,118 Nicotinamide riboside compositions for
topical use in treating skin conditions
10/30/2014 6/23/2020 4/6/2035 Owned by ChromaDex
10,689,411 Efficient and scalable syntheses of nicotinoyl
ribosides and reduced nicotinoyl ribosides,
modified derivatives thereof, phosphorylated
analogs thereof, adenylyl dinucleotide
conjugates thereof, and novel crystalline forms
thereof
11/10/2017 6/23/2020 11/10/2037 Co-owned with The Queen’s
University of Belfast and exclusively
licensed by ChromaDex
10,815,262 Methods of preparing nicotinamide riboside
and derivatives thereof
2/27/2018 10/27/2020 7/24/2034 Licensed from The Queen’s University
of Belfast
10,857,172 Use of nicotinamide riboside, nicotinic acid
riboside, and nicotinamide mononucleotide,
reduced nicotinyl compounds, and nicotinoyl
compound derivatives in infant formula for
healthy development
4/14/2017 12/8/2020 4/14/2037 Owned by ChromaDex
10,934,322 B-vitamin and amino acid conjugates of
nicotinoyl ribosides and reduced nicotinoyl
ribosides, derivatives thereof, and methods of
preparation thereof
5/11/2018 3/2/2021 3/16/2037 Co-owned with The Queen’s
University of Belfast and exclusively
licensed by ChromaDex
11,033,568 Nicotinamide riboside compositions for
topical use in treating skin conditions
6/3/2020 6/15/2021 10/30/2034 Owned by ChromaDex